Clinical Trials

Showing 281 - 300 of 510 trials
Title Investigatorsort icon Disease(s)
Assessment of Heart Tissue in Survivors of Hodgkin Lymphoma
[Protocol 14-017]
Matasar, Matthew
  • Lymphoma
    • Hodgkin's Disease
  • Survivorship
LIVESTRONG Young Adult Cancer Survivor Network Study
[Protocol 13-237]
McCabe, Mary
  • Survivorship
A Phase I Study of Oral AG-120 in Patients with Advanced Solid Tumors, Including Glioma, with an IDH1 Mutation
Relapsed/Refractory
[Protocol 14-068]
Mellinghoff, Ingo
  • Brain Tumors, Primary
    • Gliomas
  • Solid Tumors
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients
[Protocol 03-123]
Meyers, Paul
  • Hematology
    • Hematologic Malignancies
  • Sarcomas
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul
A Phase I Study of LDK378 in Children with Cancers Containing an ALK Mutation
Relapsed/Refractory
[Protocol 13-235]
Modak, Shakeel
  • Lymphoma
    • Non-Hodgkin's Lymphoma
  • Neuroblastoma
  • Sarcomas
    • Rhabdomyosarcoma
  • Solid Tumors
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090]
Modak, Shakeel
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015]
Modak, Shakeel
  • Neuroblastoma
A Pilot Phase II Study of Targeted Radiotherapy with 131I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
[Protocol 04-148]
Modak, Shakeel
  • Neuroblastoma
A Phase I Study of LJM716, BYL719, and Trastuzumab in Women with Metastatic HER2-Positive Breast Cancer
[Protocol 14-057]
Modi, Shanu
  • Breast Cancer
A Phase I Study of SGN-LIV1A in Women with Metastatic Breast Cancer
[Protocol 14-013]
Modi, Shanu
  • Breast Cancer
A Phase I Study of DLYE5953A in Patients with Advanced or Persistent Solid Tumors
[Protocol 14-089]
Modi, Shanu
  • Breast Cancer
  • Head & Neck Cancer
  • Hepatobiliary
    • Pancreatic Cancer
  • Lung Cancer, Non-Small Cell
  • Ovarian Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
    • Pancreatic Cancer
A Phase I Study of Ganetespib with Paclitaxel and Trastuzumab in Women with Metastatic Breast Cancer
[Protocol 13-168]
Modi, Shanu
  • Breast Cancer
A Phase IB Study of LEE011 and Exemestane with and without Everolimus in Women with Locally Advanced or Metastatic Breast Cancer
[Protocol 13-179]
Modi, Shanu
  • Breast Cancer
A Phase II Study of BYL719 plus AMG 479 (Ganitumab) in Patients with Advanced Ovarian Cancer or Hormone Receptor-Positive Breast Cancer
[Protocol 13-251]
Modi, Shanu
  • Breast Cancer
  • Ovarian Cancer
A Phase II Study of Neratinib to Treat Metastatic Breast Cancer that Does Not Overexpress HER2 but Has a HER2 Mutation
[Protocol 13-195]
Modi, Shanu
  • Breast Cancer
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226]
Molina, Ana Maria
  • Kidney Cancer
A Phase II Study of Transoral Surgical Removal of HPV-Positive Locally Advanced Oropharynx Cancer Followed by Risk-Stratified Therapy
Relapsed/Refractory
[Protocol 14-035]
Morris, Luc
  • Head & Neck Cancer
[18F]-Deoxy-D-Glucose (FDG) and [18F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer
[Protocol 00-095]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
    • Rising PSA After Primary Therapy